112 related articles for article (PubMed ID: 29156678)
1. Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer.
Burgermeister E; Höde P; Betge J; Gutting T; Merkel A; Wu W; Tänzer M; Mossner M; Nowak D; Magdeburg J; Rückert F; Sticht C; Breitkopf-Heinlein K; Schulte N; Härtel N; Belle S; Post S; Gaiser T; Heppner BI; Behrens HM; Röcken C; Ebert MPA
Oncotarget; 2017 Oct; 8(49):84714-84728. PubMed ID: 29156678
[TBL] [Abstract][Full Text] [Related]
2. Expression of TUSC3 and its prognostic significance in colorectal cancer.
Zhu YF; Dong M
Pathol Res Pract; 2018 Sep; 214(9):1497-1503. PubMed ID: 30115537
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells.
Kratochvílová K; Horak P; Ešner M; Souček K; Pils D; Anees M; Tomasich E; Dráfi F; Jurtíková V; Hampl A; Krainer M; Vaňhara P
Int J Cancer; 2015 Sep; 137(6):1330-40. PubMed ID: 25735931
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33/Tusc3 and its role in regulating protein N-glycosylation.
Mohorko E; Owen RL; Malojčić G; Brozzo MS; Aebi M; Glockshuber R
Structure; 2014 Apr; 22(4):590-601. PubMed ID: 24685145
[TBL] [Abstract][Full Text] [Related]
5. Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
Pils D; Horak P; Vanhara P; Anees M; Petz M; Alfanz A; Gugerell A; Wittinger M; Gleiss A; Auner V; Tong D; Zeillinger R; Braicu EI; Sehouli J; Krainer M
Cancer; 2013 Mar; 119(5):946-54. PubMed ID: 23096450
[TBL] [Abstract][Full Text] [Related]
6. TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.
Horak P; Tomasich E; Vaňhara P; Kratochvílová K; Anees M; Marhold M; Lemberger CE; Gerschpacher M; Horvat R; Sibilia M; Pils D; Krainer M
Sci Rep; 2014 Jan; 4():3739. PubMed ID: 24435307
[TBL] [Abstract][Full Text] [Related]
7. Loss of the oligosaccharyl transferase subunit TUSC3 promotes proliferation and migration of ovarian cancer cells.
Vaňhara P; Horak P; Pils D; Anees M; Petz M; Gregor W; Zeillinger R; Krainer M
Int J Oncol; 2013 Apr; 42(4):1383-9. PubMed ID: 23404293
[TBL] [Abstract][Full Text] [Related]
8. MiR-320d Inhibits Progression of EGFR-Positive Colorectal Cancer by Targeting TUSC3.
Yufeng Z; Ming Q; Dandan W
Front Genet; 2021; 12():738559. PubMed ID: 34733314
[No Abstract] [Full Text] [Related]
9.
Siri G; Mosallaei M; Ehtesham N; Rahimi H; Mazarei M; Nasrollahzadeh Sabet M; Behroozi J
Adv Biomed Res; 2023; 12():174. PubMed ID: 37564442
[TBL] [Abstract][Full Text] [Related]
10. Quantitative detection of
Duppel U; Woenckhaus M; Schulz C; Merk J; Dietmaier W
Oncol Lett; 2016 Oct; 12(4):3004-3012. PubMed ID: 27698890
[TBL] [Abstract][Full Text] [Related]
11. TUSC3: functional duality of a cancer gene.
Vašíčková K; Horak P; Vaňhara P
Cell Mol Life Sci; 2018 Mar; 75(5):849-857. PubMed ID: 28929175
[TBL] [Abstract][Full Text] [Related]
12. Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer.
Patnaik S; Anupriya
Front Pharmacol; 2019; 10():588. PubMed ID: 31244652
[TBL] [Abstract][Full Text] [Related]
13. TUSC3: a novel tumour suppressor gene and its functional implications.
Yu X; Zhai C; Fan Y; Zhang J; Liang N; Liu F; Cao L; Wang J; Du J
J Cell Mol Med; 2017 Sep; 21(9):1711-1718. PubMed ID: 28272772
[TBL] [Abstract][Full Text] [Related]
14. LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer.
Kou C; Zhou T; Han X; Zhuang H; Qian H
Biochem Biophys Res Commun; 2015 Aug; 464(2):519-25. PubMed ID: 26159916
[TBL] [Abstract][Full Text] [Related]
15. TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma.
Yan Y; Chen Z; Liao Y; Zhou J
Oncol Lett; 2019 Jun; 17(6):5073-5079. PubMed ID: 31186719
[TBL] [Abstract][Full Text] [Related]
16. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.
Jao TM; Tsai MH; Lio HY; Weng WT; Chen CC; Tzeng ST; Chang CY; Lai YC; Yen SJ; Yu SL; Yang YC
Int J Cancer; 2014 Dec; 135(11):2593-603. PubMed ID: 24740680
[TBL] [Abstract][Full Text] [Related]
17. A defect in the TUSC3 gene is associated with autosomal recessive mental retardation.
Garshasbi M; Hadavi V; Habibi H; Kahrizi K; Kariminejad R; Behjati F; Tzschach A; Najmabadi H; Ropers HH; Kuss AW
Am J Hum Genet; 2008 May; 82(5):1158-64. PubMed ID: 18452889
[TBL] [Abstract][Full Text] [Related]
18. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
Dai Y; Duan H; Duan C; Zhou R; He Y; Tu Q; Shen L
Biochem Biophys Res Commun; 2016 Jan; 469(3):430-6. PubMed ID: 26435499
[TBL] [Abstract][Full Text] [Related]
20. Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms.
Li VS; Yuen ST; Chan TL; Yan HH; Law WL; Yeung BH; Chan AS; Tsui WY; So S; Chen X; Leung SY
Gastroenterology; 2009 Jul; 137(1):176-87. PubMed ID: 19303019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
